JP Patent

JP5184777B2 — 神経変性疾患用治療薬としての選択的セロトニン２ａ／２ｃ受容体インバースアゴニスト

Assigned to アカディア ファーマシューティカルズ，インコーポレーテッド · Expires 2013-04-17 · 13y expired

What this patent protects

Patent listed against pimavanserin-tartrate.

Drugs covered by this patent

Patent Metadata

Patent number
JP5184777B2
Jurisdiction
JP
Classification
—
Expires
2013-04-17
Drug substance claim
No
Drug product claim
No
Assignee
アカディア ファーマシューティカルズ，インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.